Close
Nordic 9Nordic 9

Evolvere BioSciences (private company)

United Kingdom evolverebiosciences.com
See something wrong or missing? Let us know
Offices:Oxford
Industry:BiotechHealth servicesPharmaSoftware Services
Business model:B2B

Evolvere BioSciences is a British neo-phrama startup using computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 500k

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Evolvere BioSciences

Name Criteria
Netherlands Nori Health
60%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Ireland Relevium
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland NextImmune
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
France Qairn
60%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Signatur Biosciences
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Italy Holifya
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Netherlands Protyon
60%
  • Similar verticals: Biotech, Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Nanograb
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Bionamic
60%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Spain Nanobots Therapeutics
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Top